Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

MP-52 enters clinic

March 14, 1997

Combination of immunosuppression and rhIL-3 for aplastic anemia

March 14, 1997

SKB discloses improved antihyperlipidemic agent

March 13, 1997

Advanced-generation matrix HRT patch launched in U.K.

March 12, 1997

Green Cross claims hypolipidemic agents

March 12, 1997

Recombinant human hemoglobin produced by transgenic tobacco

March 11, 1997

Millennium obesity gene patent application receives U.S. notice of allowance

March 10, 1997

Axcan signs distribution agreements for Protectaid

March 10, 1997

AY-4166: preclinical toxicity and pharmacokinetics studies

March 10, 1997

Synaptic receives patent for "feeding" gene

March 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...